KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Depreciation and Depletion (2016 - 2022)

Historic Depreciation and Depletion for TherapeuticsMD (TXMD) over the last 13 years, with Q4 2022 value amounting to $200000.0.

  • TherapeuticsMD's Depreciation and Depletion rose 20000.0% to $200000.0 in Q4 2022 from the same period last year, while for Sep 2023 it was $200000.0, marking a year-over-year decrease of 3333.33%. This contributed to the annual value of $600000.0 for FY2022, which is 5000.0% up from last year.
  • Latest data reveals that TherapeuticsMD reported Depreciation and Depletion of $200000.0 as of Q4 2022, which was up 20000.0% from $200000.0 recorded in Q3 2022.
  • In the past 5 years, TherapeuticsMD's Depreciation and Depletion registered a high of $200000.0 during Q2 2020, and its lowest value of -$200000.0 during Q4 2021.
  • For the 5-year period, TherapeuticsMD's Depreciation and Depletion averaged around $124020.6, with its median value being $187625.0 (2019).
  • In the last 5 years, TherapeuticsMD's Depreciation and Depletion soared by 20049.88% in 2020 and then crashed by 20000.0% in 2021.
  • TherapeuticsMD's Depreciation and Depletion (Quarter) stood at $59989.0 in 2018, then surged by 193.8% to $176250.0 in 2019, then rose by 13.48% to $200000.0 in 2020, then tumbled by 200.0% to -$200000.0 in 2021, then surged by 200.0% to $200000.0 in 2022.
  • Its last three reported values are $200000.0 in Q4 2022, $200000.0 for Q3 2022, and $200000.0 during Q2 2022.